Employment Agreement Entered into on April 30, 2013 By and BetweenEmployment Agreement • July 25th, 2016 • Cellect Biotechnology Ltd. • Biological products, (no disgnostic substances)
Whereas the Employee is interested in working in the Company and the Company is interested to employ the Employee as CEO and the Company's president as specified in this agreement and all according to the manner, conditions and consideration set forth in this agreement as follows;
Amendment to Kasbian Nuriel Chirich Employment AgreementEmployment Agreement • July 25th, 2016 • Cellect Biotechnology Ltd. • Biological products, (no disgnostic substances)
This Amendment to the Employment Agreement (the “Amendment”) is made and entered into this 24th day of July, 2016 (the “Effective Date”), by and between Cellect Biotherapeutics Ltd., an Israeli company, with offices at 23 Hataas St., Kfar Saba, Israel (hereinafter the “Company”), and Kasbian Nuriel Chirich I.D. Number: 55483143, an individual whose address is 5 Hairis St., Rishpon, Israel (the “Employee”). (the Company and the Employee shall each be referred hereto as a “Party”, and collectively, as the “Parties”).
Amendment to Shai Yarkoni Employment AgreementEmployment Agreement • July 25th, 2016 • Cellect Biotechnology Ltd. • Biological products, (no disgnostic substances)
This Amendment to the Employment Agreement (the “Amendment”) is made and entered into this 24th day of July, 2016 (the “Effective Date”), by and between Cellect Biotherapeutics Ltd., an Israeli company, with offices at 23 Hataas St., Kfar Saba, Israel (hereinafter the “Company”), and Shai Yarkoni I.D. Number: 55365860, an individual whose address is 33 Halamed Hey St., Kfar Saba, Israel (the “Employee”). (the Company and the Employee shall each be referred hereto as a “Party”, and collectively, as the “Parties”).
